Quantum-Si (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 23,707 Shares of Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 23,707 shares of the company’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total transaction of $30,344.96. Following the completion of the transaction, the chief executive officer owned 2,578,018 shares of the company’s stock, valued at $3,299,863.04. This trade represents a 0.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Quantum-Si Price Performance

Shares of QSI stock opened at $1.27 on Tuesday. The business has a 50-day moving average price of $1.66 and a two-hundred day moving average price of $1.58. Quantum-Si Incorporated has a 12-month low of $0.95 and a 12-month high of $5.77. The firm has a market cap of $273.67 million, a P/E ratio of -1.90 and a beta of 2.97.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.17). The company had revenue of $0.55 million for the quarter, compared to analysts’ expectations of $0.60 million. Quantum-Si had a negative return on equity of 47.90% and a negative net margin of 3,677.97%. As a group, research analysts expect that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Canaccord Genuity Group decreased their target price on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a research report on Monday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Quantum-Si in a research note on Monday, December 8th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $3.60.

Institutional Investors Weigh In On Quantum-Si

Institutional investors have recently added to or reduced their stakes in the company. Millennium Management LLC purchased a new position in shares of Quantum-Si in the first quarter valued at about $4,721,000. Squarepoint Ops LLC bought a new stake in shares of Quantum-Si in the third quarter worth about $865,000. Geode Capital Management LLC increased its holdings in Quantum-Si by 15.1% during the 2nd quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company’s stock valued at $6,759,000 after purchasing an additional 452,850 shares during the period. Bank of America Corp DE raised its position in Quantum-Si by 426.6% during the 2nd quarter. Bank of America Corp DE now owns 465,999 shares of the company’s stock valued at $913,000 after purchasing an additional 377,504 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in Quantum-Si in the 1st quarter worth approximately $383,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Key Quantum-Si News

Here are the key news stories impacting Quantum-Si this week:

• Positive Sentiment: Launched Version 3 library‑preparation kit and a suite of data‑analysis enhancements — a commercial / product execution update that may help drive sample kit revenue, customer adoption and show progress against commercialization targets. Quantum‑Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
• Neutral Sentiment: Canaccord cut its price target from $2.00 to $1.50 and moved to a “hold” rating — the new PT still implies upside vs. current levels but reflects reduced near‑term expectations; this is a near‑term sentiment headwind from an institutional analyst. Quantum‑Si price target lowered to $1.50 from $2 at Canaccord
• Negative Sentiment: CEO Jeffrey Hawkins sold 23,707 shares at ~$1.28 (≈$30.3k), reducing his stake ~0.91% — insider selling can be viewed negatively by investors even if proceeds are modest. SEC filing — CEO sale
• Negative Sentiment: CFO Jeffry Keyes sold 8,627 shares at ~$1.28 (≈$11.0k), a ~0.74% reduction in his holding — additional insider sales this session add to selling signal. SEC filing — CFO sale
• Negative Sentiment: Director/insider John Vieceli sold 21,927 shares at ~$1.28 (≈$28.1k), trimming his stake by ~2.66% — multiple insiders selling the same day amplifies concern over near‑term insider conviction. SEC filing — Insider sale

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.